Table 4.

Outcomes of bilateral lung transplant recipients.

	Overall N = 85 (100)	Arrhythmia group N = 27 (32)	Control group N = 58 (68)	P-value
PGD° at 48 h, n (%)	6 (6)	3 (11)	3 (5)	0.377
PGD° at 72 h, n (%)	4 (4)	2 (7)	2 (3)	0.589
28-day VFD, (days)	26 (24–27)	24 [21–26]	26 [25–27]	0.10
IMV, duration (hours)	41 (24–69.75)	69.5 [24–134.5]	36 (22.5–48)	0.022
n-IMV, n (%)	70 (81.4)	21 (77.8)	49 (84.5)	0.25
n-IMV, duration (hours)	11 (5–22)	18.5 [4.5–27]	9.5 (5–18)	0.89
Pronation, n (%)	17 (19.8)	9 (33.3)	8 (13.8)	0.037
Tracheostomy, n (%)	13 (15)	8 (29.6)	5 (8.6)	0.013
IVAC57, n (%)	19 (22)	11 (40.7)	8 (13.8)	0.004
Postoperative V-A ECMO, n (%)	12 (14)	8 (29.6)	4 (6.9)	0.004
Postoperative V-A ECMO, duration (days)	0 (0–0)	0 (0–3)	0 (0–0)	0.005
Postoperative V-V ECMO, n (%)	2 (2.3)	1 (3.7)	1 (1.7)	0.56
Postoperative V-V ECMO, duration (days)	0 (0–0)	0 (0–0)	0 (0–0)	0.45
Postoperative bleeding, n (%)	9 (10.5)	3 (11.1)	6 (10.3)	0.93
Anastomotic complications, n (%	15 (17.4)	8 (29.6)	7 (12.1)	0.050
Renal replacement therapy, n (%)	6 (7)	3 (11.1)	3 (5.3)	0.33
ICU LOS, (days)	6 (4–8)	8 (6.0–14.0)	5 (4–6)	0.008
Hospital LOS, (days)	31 (28–37.5)	33 (29.75–48.75)	31 (27–36)	0.12
ICU mortality, n (%)	5 (5.8)	1 (3.7)	4 (6.9)	0.55
Hospital Mortality, N (%)	2 (2.3)	1 (3.7)	1 (1.7)	0.59

Table 4 data are expressed as number and (percentage) or median and [interquartile range].

PGD at 48 h, primary graft dysfunction = 3 at 48 h from ICU admission; PGD at 72 h, primary graft dysfunction = 3 at 72 h from ICU admission; VFD, ventilator-free days; IMV, invasive mechanical ventilation; n-IMV, non-invasive mechanical ventilation; V-A ECMO, venoarterial extracorporeal membrane oxygenation; V-V ECMO, venovenous extra-corporeal membrane oxygenation; IVAC, infection-related ventilator-associated complications; ICU, intensive care unit; LOS, length of stay.

The bold with italics values identified the significant data.